跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,418 条关于
“IRX-616a”
全部
1,418
临床试验
764
药物
512
机构
36
资讯
106
去年
InhaleRx Secures Funding for Phase 2 Trials of IRX-211 in Breakthrough Cancer Pain
去年
InhaleRx Secures $38.5M Funding to Advance Inhaled Therapies for Cancer Pain and Panic Disorder
去年
InhaleRx Secures $38.5 Million Funding to Advance Novel Inhaled Therapies for Cancer Pain and Panic Disorder
5个月前
Nexalis Therapeutics Initiates Phase 2 Trial for IRX-211 in Breakthrough Cancer Pain
去年
InhaleRx's IRX-211 Receives Approval for Phase II Breakthrough Cancer Pain Trial; Neurotech's NTI164 Shows Promise in PANDAS/PANS
去年
NRx Pharmaceuticals Plans NDA Submissions for NRX-100 and NRX-101 in Suicidal Depression
去年
NRx Pharmaceuticals Advances NRX-100 and NRX-101 for Suicidal Depression, Eyes 2024 NDA Filings
去年
Monte Rosa and Novartis Partner to Advance VAV1 Molecular Glue Degrader MRT-6160
去年
NRx Pharmaceuticals' NRX-100 (Ketamine) Achieves Stability Milestone, NDA Filing on Track
去年
Kezar's Clinical Trial of Investigational Drug KZR-616 Halted Following Patient Deaths
第 1 页,共 11 页
上一页
下一页